Literature DB >> 5171451

Levodopa, involuntary movements and fusaric acid.

I Mena, J Court, G C Cotzias.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5171451     DOI： 10.1001/jama.1971.03190250055027

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Biochemical mechanisms and management of choreiform movement disorders.

Authors:  L de Silva
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

Review 2.  Augmenting the action of levodopa.

Authors:  S K Rao; S D Vakil; D B Calne; A Hilson
Journal:  Postgrad Med J       Date:  1972-11       Impact factor: 2.401

3.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  The acetylcholine-dopamine balance in the basal ganglia of rhesus monkeys and its role in dynamic, dystonic, dyskinetic, and epileptoid motor activities.

Authors:  A R Cools; G Hendriks; J Korten
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

Review 5.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

6.  The hyperkinetic syndrome following long-term haloperidol treatment: involvement of dopamine and noradrenaline.

Authors:  D M Jackson; R Dunstan; A Perrington
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.